Loading the section…
The price of China SXT Pharmaceuticals, Inc. (SXTC) on October 9, 2026 is 0.1490 USD, -56.69% on the day. Over 52 weeks the stock traded between 0.04000 USD and 1,047.00 USD; the price now sits 0% of the way up that range. Over the past year the price changed by -99.94%.
Closing prices for 9 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Change over the period shown (line colour): −99.93 %
China SXT Pharmaceuticals, Inc. trades on Nasdaq under the ticker SXTC. The company belongs to the Health care sector. The trading history on this page starts on 4 January 2019.
Over the past 52 weeks SXTC has traded between 0.0400 $ and 1,047.00 $. As of 9 October 2026 the price stood 0.01 % of the way from the 52-week low to the high.
Over one year SXTC shares fell 99.94 %; over six months they fell 93.58 %. Volatility over 90 days is 2,127.27 %. Dividends are not included: this is price change only, as of 9 October 2026.
China SXT Pharmaceuticals, Inc. reported revenue of 2M $ and a net loss of 3M $ for the latest fiscal year. Net margin is −189.77 %. Revenue changed by −9.73 % year over year. Earnings per share are −27,852.00 $.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 0.2370 | 0.2400 | 0.1230 | 0.1490 | 110M |
| 8 October 2026 | 0.4600 | 0.4640 | 0.3100 | 0.3440 | 65M |
| 7 October 2026 | 3.19 | 9.59 | 1.87 | 2.83 | 147M |
| 6 October 2026 | 2.04 | 2.06 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 31 March 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
No events for this security recently.
Address:178 TAIDONG ROAD NORTH, TAIZHOU
SXTC has a return on equity of −21.40 %, above the sector median of −41.68 %. Return on assets is −15.25 %, above the sector median of −32.11 %. Operating margin is −153.97 %, below the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 1.18 |
| 1.25 |
| 10M |
| 5 October 2026 | 2.31 | 2.44 | 1.54 | 2.08 | 949,000 |
| 2 October 2026 | 3.00 | 3.09 | 1.94 | 2.41 | 779,100 |
| 1 October 2026 | 3.02 | 3.27 | 2.91 | 2.96 | 297,900 |
| 30 September 2026 | 2.79 | 3.10 | 2.76 | 3.01 | 186,200 |
| 29 September 2026 | 2.49 | 3.05 | 2.23 | 2.81 | 868,000 |
| 28 September 2026 | 2.59 | 2.74 | 2.52 | 2.52 | 41,700 |
| 25 September 2026 | 2.48 | 2.60 | 2.48 | 2.57 | 17,500 |
| 24 September 2026 | 2.53 | 2.60 | 2.48 | 2.55 | 40,100 |
| 23 September 2026 | 2.47 | 2.68 | 2.35 | 2.51 | 70,100 |
| 22 September 2026 | 2.31 | 2.49 | 2.30 | 2.47 | 64,000 |
| 21 September 2026 | 2.35 | 2.41 | 2.25 | 2.38 | 59,700 |
| 18 September 2026 | 2.39 | 2.48 | 2.31 | 2.40 | 55,200 |
| 17 September 2026 | 2.34 | 2.52 | 2.22 | 2.44 | 201,800 |
| 16 September 2026 | 2.34 | 2.40 | 2.13 | 2.19 | 115,200 |
| 15 September 2026 | 2.53 | 2.56 | 2.33 | 2.36 | 119,600 |
| 14 September 2026 | 2.47 | 2.72 | 2.28 | 2.66 | 309,200 |